MétaCan
Menu
← Back to cohort
Record W4409633291 · doi:10.1158/1538-7445.am2025-6978

Abstract 6978: Discovery and characterization of BAY-805, a potent and selective DUB inhibitor of ubiquitin specific peptidase USP21

2025· article· en· W4409633291 on OpenAlexaff
Norbert Schmees, Fabian Göricke, U. Scheib, Raphael Boehm, Namık Akkılıç, Gerd Wohlfahrt, Kirstin Petersen, Victoria Vu, Leanna Smith, Niels Lindner, Joerg Weiske, Ulf Boemer, Krzysztof Brzezinka, Philip Lienau, Stefan Gradl, Hartmut Beck, Peter J. Brown, Vijayaratnam Santhakumar, Masoud Vedadi, Dalia Baršytė-Lovejoy, C. Arrowsmith

Bibliographic record

VenueCancer Research · 2025
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicUbiquitin and proteasome pathways
Canadian institutionsOccupational Cancer Research CentreOntario Institute for Cancer ResearchUniversity of Toronto
Fundersnot available
KeywordsUbiquitinBiologyChemistryBiochemistryGene

Abstract

fetched live from OpenAlex

Abstract Deubiquitinases (DUBs) have recently become of high interest as some members of this protein class show potential for therapeutic interventions. The family of nearly 100 members is divided into 6 sub families. Their action is the cleavage of ubiquitin modifications from proteins, by which the function of the respective protein can change significantly. Due to this catalytic reaction all DUBs share, it is not clear so far how good specificity with potential small molecule inhibitors (SMOLs) can be achieved. Until today, only a handful of selective inhibitors were identified for a small number of protein deubiquitinases. Recent literature suggests that USP21 plays a prominent role in apoptosis, DNA repair, and signal transduction. It down-regulates TNFα-induced NF-κB activation through deubiquitinating of RIP115 and was reported to deubiquitinate RIG-I as well as STING to negatively regulate antiviral responses.16-18 Recent studies indicate the relevance of USP21 in promoting tumor development and growth, including in non-small cell lung cancer19, bladder carcinoma20, gastric cancer21, hepatocellular carcinoma22, basal-like breast cancer23, cervical cancer24, esophageal cancer25, colorectal cancer26 and pancreatic cancer27. We selected USP21 as an interesting target for oncological treatment with a focus on its immune-oncological potential. A uHTS hit finding campaign on the Bayer 4 million compound library was initiated to identify potential selective inhibitors for USP21. Selectivity was tested against 3 other USP family members and specificity by further interference assays. Binding was cross validated by thermal shift assay (TSA). Surprisingly only a very limited number of compounds passed all criteria, and one cluster was selected for optimization. The poster will show the identification of structural classes, the focus on one series and its optimization starting from the initial 12 µM HTS hit to a single digit nano-Molar probe. The probe BAY-805 shows high selectivity in biochemical assays against a larger number of USP family members and activity in a cell-based NF kB activation assay. This probe gives an opportunity to validate USP21 pharmacology under relevant conditions in cancer. Citation Format: Norbert Schmees, Fabian Göricke, Ulrike Scheib, Raphael Boehm, Namik Akkilic, Gerd Wohlfahrt, Kirstin Petersen, Victoria Vu, Leanna Smith, Niels Lindner, Joerg Weiske, Ulf Boemer, Krzysztof Brzezinka, Philip Lienau, Stefan Gradl, Hartmut Beck, Peter J. Brown, Vijayaratnam Santhakumar, Masoud Vedadi, Dalia Barsyte-Lovejoy, Cheryl Arrowsmith. Discovery and characterization of BAY-805, a potent and selective DUB inhibitor of ubiquitin specific peptidase USP21 [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 6978.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.009

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.027
GPT teacher head0.325
Teacher spread0.298 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueCancer Research→Same topicUbiquitin and proteasome pathways→French-language works237,207→